These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 16204029)
1. Activator protein 2alpha status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy. Wajapeyee N; Raut CG; Somasundaram K Cancer Res; 2005 Oct; 65(19):8628-34. PubMed ID: 16204029 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells. Zeng L; Jarrett C; Brown K; Gillespie KM; Holly JM; Perks CM Exp Cell Res; 2013 Aug; 319(14):2282-95. PubMed ID: 23810988 [TBL] [Abstract][Full Text] [Related]
3. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth. Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945 [TBL] [Abstract][Full Text] [Related]
4. Evidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-Aza-2'-deoxycytidine sensitizes human breast cancer cells to adriamycin. Xu J; Zhou JY; Tainsky MA; Wu GS Cancer Res; 2007 Feb; 67(3):1203-11. PubMed ID: 17283156 [TBL] [Abstract][Full Text] [Related]
5. AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. Orso F; Penna E; Cimino D; Astanina E; Maione F; Valdembri D; Giraudo E; Serini G; Sismondi P; De Bortoli M; Taverna D FASEB J; 2008 Aug; 22(8):2702-14. PubMed ID: 18443366 [TBL] [Abstract][Full Text] [Related]
6. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907 [TBL] [Abstract][Full Text] [Related]
7. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation. Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630 [TBL] [Abstract][Full Text] [Related]
8. Modulation of IFN-γ receptor 1 expression by AP-2α influences IFN-γ sensitivity of cancer cells. Chen C; Guo L; Shi M; Hu M; Hu M; Yu M; Wang T; Song L; Shen B; Qian L; Guo N Am J Pathol; 2012 Feb; 180(2):661-71. PubMed ID: 22182699 [TBL] [Abstract][Full Text] [Related]
9. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2'-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. Pulukuri SM; Rao JS Int J Oncol; 2005 Apr; 26(4):863-71. PubMed ID: 15753979 [TBL] [Abstract][Full Text] [Related]
10. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells. Zhang X; Leung YK; Ho SM Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739 [TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells. Menendez JA; Lupu R Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825 [TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
13. 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis. Yagi S; Oda-Sato E; Uehara I; Asano Y; Nakajima W; Takeshita T; Tanaka N Cancer Invest; 2008 Aug; 26(7):680-8. PubMed ID: 18608210 [TBL] [Abstract][Full Text] [Related]
14. Methylation silencing of the Apaf-1 gene in acute leukemia. Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851 [TBL] [Abstract][Full Text] [Related]
15. Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells. Chu SH; Ma YB; Feng DF; Zhang H; Qiu JH; Zhu ZA Mol Med Rep; 2012 Jan; 5(1):138-41. PubMed ID: 21993522 [TBL] [Abstract][Full Text] [Related]
16. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine. Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697 [TBL] [Abstract][Full Text] [Related]
17. Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibition. Wajapeyee N; Somasundaram K J Biol Chem; 2003 Dec; 278(52):52093-101. PubMed ID: 14551210 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180 [TBL] [Abstract][Full Text] [Related]
19. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
20. Involvement of transcription factor activator protein-2alpha in doxazosin-induced HeLa cell apoptosis. Gan L; Zhu DX; Yang LP; Liu RS; Yan F; Zhang J Acta Pharmacol Sin; 2008 Apr; 29(4):465-72. PubMed ID: 18358093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]